Transforming cancer healthcare through public-private partnerships
Informed Genomics is the Most Innovative Genomic Testing Company 2024 – England, that's according to the latest edition of Global Health & Pharma magazine.
To help celebrate our success, the Q2 version of the magazine has run an article by our CEO Simon Davis that looks at why healthcare partnerships are the key to unlocking access to genomic testing.
The benefits of genomic testing are widely recognised, enabling early diagnosis, personalised treatments, and improving outcomes for patients, as well as streamlining processes and delivering significant efficiencies to healthcare providers. By collaborating with like-minded healthcare and service providers across public and private sectors, Informed Genomics is successfully increasing capacity for genomic testing and helping to transform healthcare journeys for patients around the world.
Informed Genomics CEO, Simon Davis, says, “These collaborations work when both organisations are focused on the needs of the patient and share a commitment to putting quality at the heart of everything they do. We already have some fantastic projects lined up for 2024 and beyond and will continue to work with new and existing partners to help make our vision of transforming healthcare
journeys for patients a reality.”
